WHAT IS CYTOPREVENT?

A group of International Experts dedicated to changing practices to reduce potential contamination risks from occupational exposure to hazardous drugs on healthcare professionals.

Follow CytoPrevent on Twitter!

WHAT’S NEW ON CYTOPREVENT?

Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration/perfusion

Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration/perfusion

Pesqué Raphaëlle, Peyrilles Elodie, Jourdan Nathalie, Albert Odile, Sessink Paul, Madelaine Isabelle, Levert Hélène.

Occupational exposure to cytotoxic drugs can lead to significant health problems. This study was designed to evaluate the risk of 5-fluorouracil (5-FU) contamination for nurses when disconnecting the infusion line of an elastomeric pump from a non-coring needle, by comparing three configurations.

Board’s Position Paper #5

Board’s Position Paper #5

The handling of Hazardous medical drugs in a cancer treatment unit requires a specific approach in order to avoid unnecessary risks for the healthcare staff, and more particularly for the nurses. The measures to be taken concern both the preparation and administration phases.

Stop Cancer at Work Campaign calls on European Commission to approve legislation now to protect workers and patients from getting cancer

Stop Cancer at Work Campaign calls on European Commission to approve legislation now to protect workers and patients from getting cancer

The trilogue process with the European Council, Parliament and Commission under the Portuguese Presidency concludes today and there has been no discussion at all on the important legislative changes to the Carcinogens and Mutagens Directive (CMD), passed by the European Parliament to protect workers from cancer and reproductive problems at work.